Syrigos Konstantinos,Abert Istvan,Andric Zoran G,Bondarenko Igor N,Dvorkin Mikhail,Galic Kristina,Galiulin Rinat,Kuchava Vladimer,Sriuranpong Virote,Trukhin Dmytro,Zhavrid Edvard,Fu Dongyue,Kassalow Laurent M,Jones Stephanie,Bashir Zahid (2021) Efficacy and Safety of Bevacizumab Biosimilar FKB238 Versus Originator Bevacizumab: Results from AVANA, a Phase III Trial in Patients with Non-Squamous Non-Small-Cell Lung Cancer (non-sq-NSCLC), BIODRUGS, vol. 35, br. 4, str. 417-428 (Article) 

Thongprasert Sumitra,Geater Sarayut L,Clement Dana,Abdelaziz Amr,Reyes-Igama Jasmin,Jovanovic Dragana D,Alexandru Aurelia,Schenker Michael,Sriuranpong Virote,Serwatowski Piotr,Suresh Sheethal,Cseh Agnieszka,Gaafar Rabab (2019) Afatinib in locally advanced/metastatic NSCLC harboring common <i>EGFR</i> mutations, after chemotherapy: a Phase IV study, LUNG CANCER MANAGEMENT, vol. 8, br. 3, str. - (Article) 

Thongprasert Sumitra,Geater SL,Clement D,Abdelaziz A,Reyes-Igama J,Jovanovic D,Alexandru A,Schenker Michael,Sriuranpong Virote,Serwatowski P,Suresh S,Cseh Agnieszka,Gaafar Rabab (2018) Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC, ANNALS OF ONCOLOGY, vol. 29, br. , str. 146-146 (Meeting Abstract)